Login / Signup

Development and initial validation of the AL-PROfile patient-reported outcome measure in light chain (AL) amyloidosis.

Anita D SouzaAniko SzaboIdayat AkinolaMuriel FinkelKathryn E Flynn
Published in: European journal of haematology (2024)
The AL-PROfile has acceptable reliability and validity for use in systemic light chain amyloidosis patients.
Keyphrases
  • patient reported outcomes
  • end stage renal disease
  • chronic kidney disease
  • ejection fraction
  • newly diagnosed
  • peritoneal dialysis
  • prognostic factors
  • multiple myeloma